About us
Our focus
Case studies
Our people
Our portfolio
Contact

About us
Our focus
Case studies
Our people
Our portfolio
Contact

About us
Our focus
Case studies
Our people
Our portfolio
Contact

About us
Our focus
Case studies
Our people
Our portfolio
Contact

Curalogic

Exited / By Dev 1

Pharmaceutical

Curalogic

Exited / By Dev 1

Curalogics focused on creating first in class immune therapeutics, with their lead asset targeting grass pollen allergy.

History

Liquidated

Related companies

All4
Exited
Private
Public

Private

Oxular

Biotech and Drug Delivery

February 2, 2023

Private

Sequana Medical

Medtech

February 2, 2023

Post navigation

← Previous Post

Terms & conditions

Cookie policy

Registered in England No. 3941653 | VAT No. GB 765 3567 96

Website by Instinctif Partners

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in settings.

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies

If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.

Curalogic

Pharmaceutical

Curalogic

Related companies

Oxular

JenaValve

Sonendo

Sequana Medical